Clinical Study
Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation
Table 1
Patient characteristics. Data are shown for all patients and for the subgroup of SOX2-seropositive patients. LC: light chain; HC: heavy chain.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
One patient was found to bear a 13q14 and a 17p13 deletion. |